PDCD1 and cancer: Programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are both signaling molecules commonly seen on activated T cells, and have been found to be effective immunotherapeutic targets in cancer (73).